Filter
563
Text search:
laboratory
biosafety
Featured
Recommendations
92
New Publications
138
Language
Document type
No document type
289
Guidelines
128
Studies & Reports
55
Manuals
46
Strategic & Response Plan
24
Training Material
8
Situation Updates
5
Fact sheets
5
Resource Platforms
2
Brochures
1
Countries / Regions
India
33
Sierra Leone
21
Africa
18
Nigeria
17
Western and Central Europe
17
Latin America and the Carribbean
16
Ghana
12
Kenya
12
Rwanda
12
Liberia
11
Eastern Europe
11
Uganda
10
Brazil
10
Global
10
Ethiopia
8
West and Central Africa
8
Zambia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Congo, Democratic Republic of
6
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Nepal
5
South–East Asia Region
5
Russia
5
Guinea
4
Syria
4
Eastern Europe and Central Asia
4
Spain
4
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Namibia
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
202
Pharmacy & Technologies
52
Clinical Guidelines
46
Key Resources
22
Public Health
21
Women & Child Health
5
Capacity Building
1
Toolboxes
COVID-19
123
TB
102
Rapid Response
78
Ebola
60
AMR
37
HIV
14
Zika
11
NTDs
11
Conflict
9
Polio
8
Pharmacy
7
Caregiver
6
Planetary Health
6
Specific Hazards
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
2
Mental Health
1
Global Health Education
1
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u
...
The BRM ATP is an advanced course in biorisk management. The 10-day train-the-trainer course introduces the concept of biorisk management, which combines risk assessment, risk mitigation, and performance systems (AMP). The course also includes a cutting-edge training component based on the latest sc
...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de
...
A technical guide for sputum smear microscopy, initiated by the International Union against Tuberculosis, is designed to be an easy to use reference standard for the collection, storage and transport of sputum specimens and for the examination of sputum smears by direct microscopy. This edition incl
...
Instruction for Use
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI
...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t
...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an
...
La récente augmentation du nombre de cas de microcéphalie et d’autres troubles neurologiques potentiellement associés à une infection à virus Zika a engendré une recrudescence des demandes de dépistage en laboratoire de cette infection. Les groupes prioritaires pour un test de diagnostic d
...
El reciente aumento de los casos de microcefalia y de otros trastornos neurológicos posiblemente asociados a la infección por el virus de Zika ha provocado un aumento de la demanda de pruebas de laboratorio para detectar dicha infección. Los grupos prioritarios para la realización de pruebas di
...
O recente aumento dos casos de microcefalia e outras patologias neurológicas potencialmente associadas à infecção pelo vírus Zika provocou um aumento da procura de testes laboratoriais para detectar a infecção. Os grupos prioritários para os testes de diagnóstico devem ser
indivíduos sin
...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
